ICU-acquired weakness: what is preventing its rehabilitation in critically ill patients? by Christie M Lee & Eddy Fan
MINIREVIEW Open Access
ICU-acquired weakness: what is preventing its
rehabilitation in critically ill patients?
Christie M Lee1,2 and Eddy Fan1*
Abstract
Intensive care unit-acquired weakness (ICUAW) has
been recognized as an important and persistent
complication in survivors of critical illness. The
absence of a consistent nomenclature and diagnostic
criteria for ICUAW has made research in this area
challenging. Although many risk factors have been
identified, the data supporting their direct association
have been controversial. Presently, there is a growing
body of literature supporting the utility and benefit of
early mobility in reducing the morbidity from ICUAW,
but few centers have adopted this into their ICU
procedures. Ultimately, the implementation of such a
strategy would require a shift in the knowledge and
culture within the ICU, and may be facilitated by
novel technology and patient care strategies. The
purpose of this article is to briefly review the
diagnosis, risk factors, and management of ICUAW,
and to discuss some of the barriers and novel
treatments to improve outcomes for our ICU
survivors.
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Background
Decreasing mortality following critical illness over the
last few decades has shifted the focus from short-term
to long-term outcomes in intensive care unit (ICU) sur-
vivors. Survivors are often left with profound neuromus-
cular weakness resulting in persistent functional
disability and decreased quality of life for years after
hospital discharge [1,2]. Reasons for the development of
muscle weakness are multifactorial, including premorbid
conditions (for example, malignancy) and ICU-acquired
weakness (ICUAW) that may develop as a result of criti-
cal illness, systemic inflammation, and certain ICU
exposures (for example, enforced bed rest) [3]. This arti-
cle will focus on reviewing some of the more commonly
perceived causes of ICU-acquired weakness, including
hyperglycemia, exposure to corticosteroids, and the use
of neuromuscular blockers. Currently, no specific treat-
ment exists for ICUAW. Over the last decade, a number
of studies have demonstrated the safety and success of
early rehabilitation in the ICU [4-6], which may be a
promising therapy for the prevention of ICUAW. How-
ever, a number of important barriers to advancing our
knowledge of the etiology, mechanisms, prevention, and
treatment of ICUAW continue to exist. We will discuss
some of the issues surrounding early mobility in the
ICU, barriers to the implementation of early mobility,
and finally, discuss some novel ventilatory strategies to
facilitate an awake, calm, and mobile patient in the ICU.
ICUAW: a rose by any other name
The first reported cases of flaccid paralysis from periph-
eral neuropathy following sepsis was documented by
Bolton et al., in 1984 in patients unable to wean from
mechanical ventilation [7]. Since then, numerous case
series and observational studies of ICUAW have led to
an explosion in the number of terms used to describe
this syndrome [8]. Concomitantly, there has been an
evolving understanding into the various mechanisms by
which ICUAW develops, and potential therapeutic tar-
gets (for example, physical therapy) for this syndrome,
which have been recently reviewed [3,9,10]. However,
the absence of a consistent nomenclature has made
research in this area challenging, in particular, with two
systematic reviews revealing major differences in the
definition, diagnosis, reporting of outcomes, and risk
factors associated with this syndrome [11,12]. As a
result, a new scheme to diagnose and classify ICUAW
has been proposed [8]. Broad consensus by clinicians
and researchers on a common definition and diagnostic
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criteria for ICUAW would ensure consistent identifica-
tion of ICUAW patients and the ability to compare
results across studies and patient populations. Ultimately,
the diagnosis should begin with routine physical exami-
nation of a patient that is weak following an episode of
critical illness (Table 1). An initial examination should be
performed upon admission to the ICU, with subsequent
examinations paired with daily awakenings or when
patients show signs of clinical improvement allowing
cooperation with a more comprehensive examination. If
the patient has an unreliable exam and/or is persistently
weak, electrophysiological testing (for example, electro-
myography (EMG) and nerve conduction studies (NCS))
and/or muscle biopsy may be considered [8].
Risk factors and prevention of ICUAW
In the last decade, studies have identified a number of
risk factors for ICUAW, but most are small, observa-
tional studies with important methodological limitations
[9,12]. There are limited and conflicting data regarding
the association between severity of illness and ICUAW
[9]. Indeed, critical illness neuromyopathy (an important
cause of ICUAW) itself is a form of neuromuscular organ
failure and similar attention should be placed on preven-
tion and recovery, much the same way that we would
approach acute kidney or lung injury.
Hyperglycemia may be an important risk factor for the
development of ICUAW. Post hoc analyses of two large
randomized control trials looking at intensive insulin
therapy in both surgical and medical ICUs reported a sig-
nificant reduction in ICUAW with tight glycemic control
[13,14]. However, the results of these secondary analyses
and the safety of intensive insulin therapy remains con-
troversial and clinicians should be cautious in using tight
glycemic control for the prevention of ICUAW.
There remains substantial controversy regarding the
association of ICUAW with two other commonly cited
risk factors: corticosteroids and neuromuscular blocking
agents (NMBA). Although three prospective observa-
tional studies have shown increased risk of ICUAW
with corticosteroid exposure [1,15,16], a number of stu-
dies have also failed to show a significant association
[12,17]. Similarly, despite early evidence to suggest per-
sistent weakness after prolonged infusion of vecuronium
[18], subsequent studies evaluating NMBAs have not
supported any significant association with ICUAW.
Importantly, a recent trial of patients with early acute
respiratory distress syndrome (ARDS) randomized to
cisatricurium demonstrated a significant reduction in
28-day mortality, without any significant difference in
ICUAW as compared to the placebo group [19]. In the
end, the decision to use corticosteroids and/or NMBA
requires a case-by-case review of the potential benefits
and risks, and clinicians must be aware of all the evi-
dence in order to make an informed decision.
Barriers to early mobility in the ICU
In recent years, a number of studies have documented the
safety and feasibility of early mobility in the ICU [4-6]. In
addition, early rehabilitation is associated with important
reductions in delirium, duration of mechanical ventilation,
and improved physical function at hospital discharge [20].
Despite this, only about 25% of all ICU patients receive
early therapy [21]. A number of important barriers, both
real and perceived, to implementing early rehabilitation at
the patient (for example, delirium, hemodynamic instabil-
ity), provider (for example, staff discomfort, decreased
awareness about the importance of early mobility), and
institutional (for example, lack of facilities, personnel,
equipment) levels have been identified [21,22]. Commonly
cited reason for not receiving therapy include oversedation
or coma, lack of available rehabilitation staff, and some
potentially avoidable including inappropriate vascular
access positions, conflict with another planned procedure,
Table 1 Clinical, electrophysiological, and histological features of intensive care unit-acquired weakness (ICUAW)
Investigation CIP CIM CINM
Physical
examination
Distal muscle weakness Proximal muscle weakness Proximal and distal muscle weakness
Distal sensory deficit Normal sensory testing Distal sensory deficit
Normal or depressed deep
tendon reflexes
Normal or depressed deep tendon
reflexes
Depressed deep tendon reflexes
Electrophysiology
studies
Decreased CMAP and decreased
SNAP
Decreased CMAP and normal SNAP Decreased CMAP and SNAP
Normal MUAP Decreased MUAP Decreased MUAP
Normal or near-normal
conduction velocity
EMG shows short duration, low
amplitude activity
EMG shows short duration, low-amplitude activity
Histology Axonal degeneration of distal
motor and sensory nerves
Thick filament (myosin) loss, type II fiber
(fast twitch) atrophy, necrosis
Axonal degeneration and evidence of loss in
myosin, type II fiber atrophy, and necrosis
CIM = critical illness myopathy; CINM = critical illness neuromyopathy; CIP = critical illness polyneuropathy; CMAP = compound muscle action potential; EMG =
electromyography; MUAP = muscle unit action potential; SNAP= sensory nerve action potential.
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and poor sedation management and agitation [21]. While
simply pairing physical therapy sessions with sedative
interruption may enhance the delivery of early rehabilita-
tion, ultimately, overcoming these barriers will require the
creation of an ICU culture that prioritizes early rehabilita-
tion through interdisciplinary coordination, communica-
tion, and teamwork. Educational strategies focused on the
complications of oversedation (for example, bed rest/
immobility, delirium) and its effects on both the short-
term and long-term outcomes (for example, ICUAW, neu-
rocognitive/neuropsychiatric morbidity) may help to facili-
tate culture change. These elements are essential in
ensuring the successful and sustained implementation of
such a complex intervention. Finally, the barriers, facilita-
tors, and efficacy of early rehabilitation have been evalu-
ated primarily in medical ICU patients; the applicability of
these practices in other ICUs (for example, neurologic,
trauma, pediatric) require exploration in future clinical
trials.
Early rehabilitation in the ICU: future directions
Novel rehabilitation technology, such as neuromuscular
electrical stimulation (NMES) and cycle ergometry, may
provide an opportunity for early rehabilitation even when
the patient is unable to actively participate (for example,
during acute phase of critical illness). In healthy volun-
teers, NMES can improve or preserve muscle strength by
preventing disuse atrophy through stimulated muscle
contraction [23], but there are limited data in the criti-
cally ill. In a study of mechanically ventilated patients
with chronic obstructive pulmonary disease (COPD),
those randomized to NMES with physical therapy had
improved muscle strength at 28 days and decreased num-
ber of days needed to transfer from bed to chair as com-
pared to physical therapy alone [24]. Cycle ergometry,
another novel rehabilitation tool can provide passive,
active-assisted, or active range of motion exercises [23].
In a recent study of ninety critically ill patients, those
randomized to cycle ergometry showed improvements in
quadriceps muscle function, 6-minute walk distance, and
self-reported physical functioning at hospital discharge
[25]. These promising results require confirmation in
large, prospective clinical trials.
Enforced bedrest, oversedation, and delirium are com-
mon barriers to early rehabilitation in the ICU. Sedation
and analgesia are commonly instituted (with or without
neuromuscular blockade) in the ICU for management of
patient discomfort, anxiety, and asynchrony during
mechanical ventilation. Changes in sedation strategies,
including novel sedative agents such as dexmedetomi-
dine [26], use of intermittent sedation [27], or no seda-
tion [28] may help to limit oversedation and delirium in
the ICU and improve patient wakefulness and availabil-
ity for physical therapy.
Even more radical might be finding a viable alternative
to mechanical ventilation in which sedation and analgesia
use can truly be minimized. Extracorporeal membrane
oxygenation (ECMO) has become an area of increasing
interest following its successful use for H1N1-associated
ARDS [29]. By providing extracorporeal gas exchange
support, ECMO may mitigate the need for any aggressive
mechanical ventilation in patients with respiratory failure.
Indeed, a number of groups have exploited this technol-
ogy to facilitate rehabilitation and ambulation in ICU
patients awaiting lung transplantation [30,31]. As this
technology continues to improve and miniaturize, it is
conceivable that mechanical ventilation could eventually
be replaced by ECMO, allowing our critically ill patients
to be awake, calm, cooperative, and mobile.
Conclusions
ICUAW is an important complication that contributes to
functional disability and decreased quality of life in ICU
survivors. Indeed, it is an important component of the
post-intensive care syndrome (PCIS) representing any
new or worsening impairment in physical, cognitive, or
mental heath status following an acute care hospitaliza-
tion [32]. The lack of an accepted taxonomy and diagnos-
tic criteria for ICUAW has made it difficult to interpret
and compare results across studies. Early rehabilitation
may be an important preventative therapy for ICUAW,
but there are many important barriers at the patient, pro-
vider, and organizational levels which need to be recog-
nized and overcome. Novel rehabilitation (for example,
NMES, cycle ergometry) technology may facilitate reha-
bilitation in patients who cannot actively participate in
therapy during the acute phase of their illness. Finally,
ECMO may obviate the need for heavy sedation/analgesia
and mechanical ventilation, providing a means to provide
early rehabilitation to patients with even the most severe
forms of respiratory failure in the ICU. The combination
of: (1) a coordinated interdisciplinary team; (2) novel
advances in both ICU and rehabilitation technology; and
(3) a culture that prioritizes early rehabilitation, will help
our ICU patients to be awake, calm, cooperative, and
mobile, and hopefully translate into substantial improve-
ments in both their short-term and long-term outcomes.
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